Clinical trial for Atrial Fibrillation (AF)
Official title Substrate Remodelling and Targeted Ablation in AF
ClinicalTrials.gov ID: NCT07047235
What this study is testing
- What it's testing
- The study wants to see if using a 3‑D electrical map of the heart during ablation reduces repeat procedures and improves quality of life.
- Who it's for
- Adults with atrial fibrillation who are scheduled for catheter ablation.
- What's involved
- Participants will have a standard catheter ablation plus detailed electro‑anatomical mapping; if AF returns they may have a second, map‑guided ablation, plus scheduled clinic visits and 48‑hour heart rhythm recordings.
- Time commitment
- The study follows participants for 12 months with visits at 3, 6, 9 and 12 months and ECG monitoring at 6 and 12 months.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Able and willing to provide written informed consent
- Age: 18 years or older
- Clinical diagnosis: Persistent atrial fibrillation
- Treatment status: Scheduled to undergo first-time catheter ablation for persistent AF
You likely can't join if
- Inability or unwillingness to provide informed consent
- Under 18 years of age
- Previous left atrial ablation for AF or other atrial arrhythmias
- Any clinical contraindications to undergoing AF catheter ablation
The study team makes the final eligibility decision.
Where it is enrolling
- London, United Kingdom
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at London, United Kingdom. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.